| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pain, Postoperative | D010149 | 13 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Abnormalities, Drug-Induced | D000014 | 10 associated lipids |
| Hypersensitivity, Delayed | D006968 | 43 associated lipids |
| Staphylococcal Infections | D013203 | 15 associated lipids |
| Corneal Opacity | D003318 | 3 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
| Eye Diseases | D005128 | 12 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Sidhu H et al. | Risk assessment of biosolids-borne ciprofloxacin and azithromycin. | 2019 | Sci. Total Environ. | pmid:30463165 |
| Sidhu H et al. | Plant toxicity and accumulation of biosolids-borne ciprofloxacin and azithromycin. | 2019 | Sci. Total Environ. | pmid:30340267 |
| Sidhu H et al. | Retention-release of ciprofloxacin and azithromycin in biosolids and biosolids-amended soils. | 2019 | Sci. Total Environ. | pmid:30196217 |
| Sidhu H et al. | Bioavailability of biosolids-borne ciprofloxacin and azithromycin to terrestrial organisms: Microbial toxicity and earthworm responses. | 2019 | Sci. Total Environ. | pmid:30195128 |
| Latif AS et al. | Antimicrobial susceptibility in isolates from five sentinel surveillance sites in Zimbabwe, 2015-2016. | 2018 | Sex Transm Infect | pmid:28476914 |
| Å majs D and PospÃÅ¡ilová P | Macrolide resistance in yaws. | 2018 | Lancet | pmid:29428184 |
| Mitjà O et al. | Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study. | 2018 | Lancet | pmid:29428183 |
| Brereton CJ et al. | Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study. | 2018 | Int. J. Antimicrob. Agents | pmid:29410326 |
| Ting CY and Shahdadpuri R | Fuchs syndrome: a case of fever, mucositis and conjunctivitis. | 2018 | BMJ Case Rep | pmid:29378740 |
| Huang S et al. | Human babesiosis in Southeast China: A case report. | 2018 | Int. J. Infect. Dis. | pmid:29355731 |
| Jenson A et al. | Patient-centered communication of community treatment assistants in Tanzania predicts coverage of future mass drug administration for trachoma. | 2018 | Patient Educ Couns | pmid:29329726 |
| Sarathchandran P et al. | infection presenting as stroke and meningoencephalitis with aortic and subclavian aneurysms without pulmonary involvement. | 2018 | BMJ Case Rep | pmid:29326371 |
| Mascarenhas TR et al. | Tick-borne illness after transplantation: Case and review. | 2018 | Transpl Infect Dis | pmid:29277955 |
| Oldenburg CE et al. | Comparison of Mass Azithromycin Coverage Targets of Children in Niger: A Cluster-Randomized Trachoma Trial. | 2018 | Am. J. Trop. Med. Hyg. | pmid:29260659 |
| Medeiros PHQS et al. | Molecular characterization of virulence and antimicrobial resistance profile of Shigella species isolated from children with moderate to severe diarrhea in northeastern Brazil. | 2018 | Diagn. Microbiol. Infect. Dis. | pmid:29217418 |
| Kelly C et al. | Macrolide antibiotics for bronchiectasis. | 2018 | Cochrane Database Syst Rev | pmid:29543980 |
| Casas-Maldonado F | Bronchiectasis and Azithromycin. | 2018 | Arch. Bronconeumol. | pmid:28757281 |
| Zhao L et al. | Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014. | 2018 | Int. J. Antimicrob. Agents | pmid:28729124 |
| Bakshi SS | In reference to 'Therapeutic efficacy of azithromycin and acetylcysteine in chronic otitis media with effusion'. | 2018 | Eur Arch Otorhinolaryngol | pmid:28612316 |
| Weston EJ et al. | Adherence to CDC Recommendations for the Treatment of Uncomplicated Gonorrhea - STD Surveillance Network, United States, 2016. | 2018 | MMWR Morb. Mortal. Wkly. Rep. | pmid:29698384 |
| Revello R et al. | Prediction of chorioamnionitis in cases of intraamniotic infection by ureaplasma urealyticum in women with very preterm premature rupture of membranes or preterm labour. | 2018 | J. Matern. Fetal. Neonatal. Med. | pmid:28502201 |
| Keenan JD et al. | Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa. | 2018 | N. Engl. J. Med. | pmid:29694816 |
| Marks M et al. | Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea. | 2018 | Lancet Glob Health | pmid:29456191 |
| Sardana K et al. | An observational study of the efficacy of azithromycin in erythema annulare centrifugum. | 2018 | Clin. Exp. Dermatol. | pmid:29297941 |
| Lietman TM et al. | Identifying a sufficient core group for trachoma transmission. | 2018 | PLoS Negl Trop Dis | pmid:30296259 |
| Hassan KS and Al-Khadouri G | Pneumonia with Worsening Pleural Effusion Despite Treatment with Appropriate Antimicrobials: Case report. | 2018 | Sultan Qaboos Univ Med J | pmid:30210860 |
| Williams PCM and Berkley JA | Guidelines for the management of paediatric cholera infection: a systematic review of the evidence. | 2018 | Paediatr Int Child Health | pmid:29790841 |
| Al-Darraji A et al. | Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease. | 2018 | PLoS ONE | pmid:30001416 |
| Glanternik JR et al. | A Cluster of Cases of Babesia microti Among Neonates Traced to a Single Unit of Donor Blood. | 2018 | Pediatr. Infect. Dis. J. | pmid:28945680 |
| Vermillion Maier ML and Tjeerdema RS | Azithromycin sorption and biodegradation in a simulated California river system. | 2018 | Chemosphere | pmid:29031188 |
| Tada H et al. | The effects of Lactobacillus reuteri probiotics combined with azithromycin on peri-implantitis: A randomized placebo-controlled study. | 2018 | J Prosthodont Res | pmid:28756115 |
| Fleming-Dutra KE et al. | Variations in Antibiotic and Azithromycin Prescribing for Children by Geography and Specialty-United States, 2013. | 2018 | Pediatr. Infect. Dis. J. | pmid:28746259 |
| Balci O and Gulkilik G | Assessment of efficacy of topical azithromycin 1.5 per cent ophthalmic solution for the treatment of meibomian gland dysfunction. | 2018 | Clin Exp Optom | pmid:28677153 |
| Obaro S | Azithromycin and Childhood Mortality in Africa. | 2018 | N. Engl. J. Med. | pmid:30284804 |
| Michelow IC and Sánchez PJ | Azithromycin and Childhood Mortality in Africa. | 2018 | N. Engl. J. Med. | pmid:30284803 |
| Cutler T et al. | Azithromycin and Childhood Mortality in Africa. | 2018 | N. Engl. J. Med. | pmid:30284802 |
| Keenan JD et al. | Azithromycin and Childhood Mortality in Africa. | 2018 | N. Engl. J. Med. | pmid:30281987 |
| Smotrys M et al. | Babesiosis as a cause of false-positive HIV serology. | 2018 | BMJ Case Rep | pmid:29884713 |
| Nüesch-Inderbinen M et al. | Genetic characterization of Shiga toxin producing Escherichia coli belonging to the emerging hybrid pathotype O80:H2 isolated from humans 2010-2017 in Switzerland. | 2018 | Int. J. Med. Microbiol. | pmid:29884331 |
| Iguidbashian JP et al. | and coinfection in the setting of ulcerative colitis. | 2018 | BMJ Case Rep | pmid:29880626 |
| Lendermon EA et al. | Azithromycin Fails to Prevent Accelerated Airway Obliteration in T-bet Mouse Lung Allograft Recipients. | 2018 | Transplant. Proc. | pmid:29880387 |
| Lam-Franco L et al. | IL-1α and MMP-9 Tear Levels of Patients with Active Ocular Rosacea before and after Treatment with Systemic Azithromycin or Doxycycline. | 2018 | Ophthalmic Res. | pmid:29874670 |
| Saita MG et al. | pH-Dependent stability of azithromycin in aqueous solution and structure identification of two new degradation products. | 2018 | J Pharm Biomed Anal | pmid:29860178 |
| Naderi N et al. | Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease. | 2018 | Respir Med | pmid:29724384 |
| Zmora N et al. | Open label comparative trial of mono versus dual antibiotic therapy for Typhoid Fever in adults. | 2018 | PLoS Negl Trop Dis | pmid:29684022 |
| Wei W et al. | MPEG-PCL Copolymeric Micelles for Encapsulation of Azithromycin. | 2018 | AAPS PharmSciTech | pmid:29675667 |
| Barge L et al. | Transient immune-mediated agranulocytosis following infection. | 2018 | BMJ Case Rep | pmid:29669774 |
| Baker KS et al. | Horizontal antimicrobial resistance transfer drives epidemics of multiple Shigella species. | 2018 | Nat Commun | pmid:29654279 |
| Ganesh R et al. | Clinical profile and outcome of children with scrub typhus from Chennai, South India. | 2018 | Eur. J. Pediatr. | pmid:29637374 |
| Deguchi T et al. | Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis. | 2018 | J. Infect. Chemother. | pmid:29627327 |